http://purl.org/np/RA9Ck_IDLoD5h74Ky3zX55OudJBgAuqwKdH02D-_Ah3C0#Head http://purl.org/np/RA9Ck_IDLoD5h74Ky3zX55OudJBgAuqwKdH02D-_Ah3C0 http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RA9Ck_IDLoD5h74Ky3zX55OudJBgAuqwKdH02D-_Ah3C0#assertion http://purl.org/np/RA9Ck_IDLoD5h74Ky3zX55OudJBgAuqwKdH02D-_Ah3C0 http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RA9Ck_IDLoD5h74Ky3zX55OudJBgAuqwKdH02D-_Ah3C0#provenance http://purl.org/np/RA9Ck_IDLoD5h74Ky3zX55OudJBgAuqwKdH02D-_Ah3C0 http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RA9Ck_IDLoD5h74Ky3zX55OudJBgAuqwKdH02D-_Ah3C0#pubinfo http://purl.org/np/RA9Ck_IDLoD5h74Ky3zX55OudJBgAuqwKdH02D-_Ah3C0 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RA9Ck_IDLoD5h74Ky3zX55OudJBgAuqwKdH02D-_Ah3C0#assertion http://purl.obolibrary.org/obo/DOID_0050782 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RA9Ck_IDLoD5h74Ky3zX55OudJBgAuqwKdH02D-_Ah3C0#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_0050782 http://purl.org/np/RA9Ck_IDLoD5h74Ky3zX55OudJBgAuqwKdH02D-_Ah3C0#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RA9Ck_IDLoD5h74Ky3zX55OudJBgAuqwKdH02D-_Ah3C0#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB00213 http://purl.org/np/RA9Ck_IDLoD5h74Ky3zX55OudJBgAuqwKdH02D-_Ah3C0#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RA9Ck_IDLoD5h74Ky3zX55OudJBgAuqwKdH02D-_Ah3C0#association http://www.w3.org/2000/01/rdf-schema#label pantoprazole sodium delayed release tablets are indicated for pantoprazole sodium delayed release tablet is a proton pump inhibitor indicated for the following short term treatment of erosive esophagitis associated with gastroesophageal reflux disease gerd 1 1 maintenance of healing of erosive esophagitis 1 2 pathological hypersecretory conditions including zollinger ellison syndrome 1 3 pantoprazole sodium delayed release tablets are indicated in adults for the short term treatment up to 8 weeks in the healing and symptomatic relief of erosive esophagitis for those adult patients who have not healed after 8 weeks of treatment an additional 8 week course of pantoprazole sodium delayed release tablets may be considered safety of treatment beyond 8 weeks in pediatric patients has not been established pediatric indication and usage information in pediatric patients ages five years and older with erosive esophagitis associated with gerd is approved for wyeth pharmaceuticals inc s pantoprazole sodium delayed release tablets however due to wyeth pharmaceuticals inc s marketing exclusivity rights this drug product is not labeled with that pediatric information pantoprazole sodium delayed release tablets are indicated for maintenance of healing of erosive esophagitis and reduction in relapse rates of daytime and nighttime heartburn symptoms in adult patients with gerd controlled studies did not extend beyond 12 months pantoprazole sodium delayed release tablets are indicated for the long term treatment of pathological hypersecretory conditions including zollinger ellison syndrome http://purl.org/np/RA9Ck_IDLoD5h74Ky3zX55OudJBgAuqwKdH02D-_Ah3C0#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RA9Ck_IDLoD5h74Ky3zX55OudJBgAuqwKdH02D-_Ah3C0#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RA9Ck_IDLoD5h74Ky3zX55OudJBgAuqwKdH02D-_Ah3C0#association https://w3id.org/biolink/vocab/relation https://schema.org/TreatmentIndication https://identifiers.org/drugbank:DB00213 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RA9Ck_IDLoD5h74Ky3zX55OudJBgAuqwKdH02D-_Ah3C0#provenance http://purl.org/np/RA9Ck_IDLoD5h74Ky3zX55OudJBgAuqwKdH02D-_Ah3C0#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RA9Ck_IDLoD5h74Ky3zX55OudJBgAuqwKdH02D-_Ah3C0#pubinfo http://purl.org/np/RA9Ck_IDLoD5h74Ky3zX55OudJBgAuqwKdH02D-_Ah3C0#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RA9Ck_IDLoD5h74Ky3zX55OudJBgAuqwKdH02D-_Ah3C0#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RA9Ck_IDLoD5h74Ky3zX55OudJBgAuqwKdH02D-_Ah3C0#sig http://purl.org/nanopub/x/hasSignature S3eIvejtRf8FiJOESd9w+dCee2GFRruykKEegSz5P1R6MY/fbIY/eMx4tG4qnJcQw8CqMszIf035q49UUPG5IE83Dn4MdbpCzQBqP5JyMpxnhXTxz89MwAGghxHnetOIG+ZdGEtFJt2sOJuymbxKZIDkcCme5tIU4TdYoxPVTTo= http://purl.org/np/RA9Ck_IDLoD5h74Ky3zX55OudJBgAuqwKdH02D-_Ah3C0#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RA9Ck_IDLoD5h74Ky3zX55OudJBgAuqwKdH02D-_Ah3C0 http://purl.org/np/RA9Ck_IDLoD5h74Ky3zX55OudJBgAuqwKdH02D-_Ah3C0 http://purl.org/dc/terms/created 2021-06-27T20:22:01.260+02:00 http://purl.org/np/RA9Ck_IDLoD5h74Ky3zX55OudJBgAuqwKdH02D-_Ah3C0 http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RA9Ck_IDLoD5h74Ky3zX55OudJBgAuqwKdH02D-_Ah3C0 https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RA9Ck_IDLoD5h74Ky3zX55OudJBgAuqwKdH02D-_Ah3C0 https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RA9Ck_IDLoD5h74Ky3zX55OudJBgAuqwKdH02D-_Ah3C0 https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs